Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 543,276 | 538,763 | 541,742 | 299,845 | 138,530 |
| Cost of Goods | 64,460 | 151,729 | 254,767 | 279,457 | 639 |
| Gross Profit | 478,816 | 387,034 | 286,975 | 20,388 | 137,891 |
| Operating Expenses | 408,443 | 389,233 | 371,607 | 1,068,201 | 67,129 |
| Operating Income | 70,833 | -1,470 | -83,865 | -1,047,356 | 71,401 |
| Other Income | -1,573 | 6,413 | 11,726 | -19,504 | 1,986 |
| Pre-tax Income | 69,260 | 4,943 | -72,139 | -1,066,860 | 73,387 |
| Income Tax | 32,492 | 4,116 | -30,941 | -76,297 | 27,887 |
| Net Income Continuous | 36,768 | 827 | -41,198 | -990,563 | 45,500 |
| Net Income | $36,768 | $827 | $-41,198 | $-990,563 | $45,500 |
| EPS Basic Total Ops | 0.11 | 0.00 | -0.12 | -5.66 | 0.29 |
| EPS Basic Continuous Ops | 0.11 | 0.00 | -0.12 | -5.66 | 0.29 |
| EPS Diluted Total Ops | 0.10 | 0.00 | -0.12 | -5.59 | 0.26 |
| EPS Diluted Continuous Ops | 0.10 | 0.00 | -0.12 | -5.56 | 0.25 |
| EBITDA(a) | $200,467 | $100,086 | $17,921 | $-996,008 | $75,258 |